SCHEMBL7604120

SCHEMBL7604120

CCCN(CCC)C(=O)c1cccc(C(=O)NC(Cc2cc(F)cc(F)c2)[C@@H](O)C[C@@H](CC)C(=O)NCC(C)C)c1

nearest known ligand 0.86

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 20/20 0.86
BACE2 Q9Y5Z0 19/20 0.86

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4881963 1.00 BACE1 (0.86) BACE1BACE2
SCHEMBL25915985 0.93 BACE1 (1.00) BACE1BACE2
SCHEMBL14258641 0.91 BACE1 (0.81) BACE1BACE2
SCHEMBL4883151 0.90 BACE1 (0.88) BACE1BACE2
SCHEMBL7609802 0.90 BACE1 (0.88) BACE1BACE2
SCHEMBL7607163 0.89 BACE1 (0.84) BACE1BACE2
SCHEMBL4890341 0.89 BACE1 (0.84) BACE1BACE2
SCHEMBL7603646 0.89 BACE1 (1.00) BACE1BACE2
SCHEMBL4888346 0.89 BACE1 (1.00) BACE1BACE2
SCHEMBL4890158 0.89 BACE1 (0.85) BACE1BACE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1265849-A2 COMPOUNDS AND METHODS TO TREAT ALZHEIMER'S DISEASE Elan Pharmaceuticals, Inc. (US) 2002-12-18 EP claimed
WO-2001070672-A2 COMPOUNDS AND METHODS TO TREAT ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2001-09-27 WO claimed
EP-1265849-A2 COMPOUNDS AND METHODS TO TREAT ALZHEIMER'S DISEASE Elan Pharmaceuticals, Inc. (US) 2002-12-18 EP disclosed
WO-2001070672-A2 COMPOUNDS AND METHODS TO TREAT ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2001-09-27 WO disclosed